What is CVE-2021-26726?

CVE-2021-26726 is a high-severity vulnerability in Valmet Dna, classified under OS Command Injection. CVSS score: 8.8/10. Published 2022-02-16.

How severe is CVE-2021-26726?

High severity. CVSS v3 base score is 8.8 out of 10.

RCE in Valmet Dna

CVE-2021-26726

A remote code execution vulnerability affecting a Valmet DNA service listening on TCP port 1517, allows an attacker to execute commands with SYSTEM privileges This issue affects: Valmet DNA versions from Collection 2012 until Collection 20…

Vulnerability class: Command Injection (OS Command Injection)

EPSS: 0.011 (63.3th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 8.8 (High). Vector: CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.

Affected products

Valmet Dna
Valmet Dna — versions Collection 2012

Weakness classification (CWE)

References

prodsec@nozominetworks.com (x_refsource_CONFIRM, Third Party Advisory)
prodsec@nozominetworks.com (x_refsource_MISC, Vendor Advisory)

Frequently asked questions

What is CVE-2021-26726?: CVE-2021-26726 is a high-severity vulnerability in Valmet Dna, classified under OS Command Injection. CVSS score: 8.8/10. Published 2022-02-16.
How severe is CVE-2021-26726?: High severity. CVSS v3 base score is 8.8 out of 10.